Bank of New York Mellon
NDRM

Bank of New York Mellon’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Bank of New York Mellon’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-14,003
Closed -$259K – 4403
2016
Q3 		$259K Sell
14,003
-1,112
-7% -$19.3K ﹤0.01% 3819
2016
Q2 		$246K Buy
+15,115
New +$255K ﹤0.01% 3825

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon's NDRM Position: Q4 2016 in Review

Bank of New York Mellon sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 14,003 shares — an estimated $259K sold.

Bank of New York Mellon first reported a position in NDRM in Q2 2016 and held it in 2 quarters. The position peaked at $259K in Q3 2016. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • Bank of New York Mellon reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 14,003 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $259K.
  • Bank of New York Mellon first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2016 and held it in 2 quarters.
  • Bank of New York Mellon's NeuroDerm Ltd. Ordinary Shares position peaked at $259K in Q3 2016.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.